FDA to End Free Pass on Pediatric Studies of Orphan Drugs, Gottlieb Says

Drug Industry Daily
A A
The FDA will move to close a loophole in the program to foster study of treatments for rare pediatric illnesses, agency commissioner Scott Gottlieb said in a blog post.

To View This Article:

Login

Subscribe To Drug Industry Daily